Protocol Title: An Open-label Phase 2 Proof-of-Concept Study in Patients with C3 Glomerulopathy (C3G) or Immune- Complex Membranoproliferative Glomerulonephritis (ICMPGN) Treated with ACH-0144471 (ACH471-205)

Recruitment Status

Open

Contact the research team to learn more about this study.

Please verify that you are not a bot.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Volunteer Sign up

Volunteer Sign-up

Participate in medical studies to develop new diagnostic and clinical treatments and improve current standards of care.

Sign Up Now!

If you need assistance finding a study or if you have any questions, please email: info@trialx.com